BCI
PMC

Brinker Capital Investments’s PharMerica Corporation PMC Stock Holding History

Brinker Capital Investments’s Portfolio PMC Stock Details PMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-16
Closed – – 429
2013
Q4 		$0 Buy
+16
New +$291 ﹤0.01% 421

Other funds holding PMC

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Brinker Capital Investments's PMC Position: Q1 2014 in Review

Brinker Capital Investments sold out of PharMerica Corporation (PMC) in Q1 2014, closing a stake of 16 shares.

Brinker Capital Investments first reported a position in PMC in Q4 2013 and held it in 1 quarter. The position peaked at $0 in Q4 2013. 161 funds tracked by Wall St. Rank hold PMC as of Q1 2014.

  • Brinker Capital Investments reported no remaining PharMerica Corporation position as of Q1 2014 after selling out during the quarter.
  • Brinker Capital Investments sold 16 PharMerica Corporation shares in Q1 2014.
  • Brinker Capital Investments first reported a position in PharMerica Corporation in Q4 2013 and held it in 1 quarter.
  • Brinker Capital Investments's PharMerica Corporation position peaked at $0 in Q4 2013.
  • 161 funds tracked by Wall St. Rank held PharMerica Corporation as of Q1 2014.

Based on Brinker Capital Investments's 13F filing for Q1 2014, filed 13 May 2014.